logo

For the Inventor, By the Inventor

Hayward, CA, United States of America

Gail L Barchfeld

This inventor holds 5 USPTO granted patents. Top assignee: Chiron Corporation. Active years: 1998-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gail L Barchfeld. Retrieved from https://idiyas.com/inventor/gail-l-barchfeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 278(Granted Patents)


Location History:

  • Alameda, CA (US) (2001 - 2002)
  • Hayward, CA (US) (1998 - 2006)

Company Filing History:

goldMedal5 out of 672 
 
Chiron Corporation
 patents

Years Active: 1998-2006

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7056521 - Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants (2006-06-06),
2. 6818222 - Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants (2004-11-16),
3. 6451325 - Adjuvant formulation comprising a submicron oil droplet emulsion (2002-09-17),
4. 6299884 - Adjuvant formulation comprising a submicron oil droplet emulsion (2001-10-09),
5. 5709879 - Vaccine compositions containing liposomes (1998-01-20),

Title: Gail L Barchfeld: Innovator in Bacterial Toxin Research

Introduction

Gail L Barchfeld is a prominent inventor based in Hayward, California. She has made significant contributions to the field of biotechnology, particularly in the development of detoxified mutants of bacterial ADP-ribosylating toxins. With a total of five patents to her name, Barchfeld's work has the potential to impact vaccine development and immunology.

Latest Patents

Among her latest patents, Barchfeld has developed parenteral adjuvants comprising detoxified mutants of bacterial ADP-ribosylating toxins. These toxins are derived from pertussis (PT), cholera (CT), and heat-labile (LT). Her innovative approach aims to enhance the efficacy of vaccines by utilizing these detoxified mutants as adjuvants.

Career Highlights

Barchfeld has had a successful career at Chiron Corporation, where she has been instrumental in advancing research in her field. Her expertise in bacterial toxins has positioned her as a leader in the development of new immunological strategies.

Collaborations

Throughout her career, Barchfeld has collaborated with notable colleagues, including Gary S Ott and Gary Van Nest. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gail L Barchfeld's contributions to the field of biotechnology and her innovative patents highlight her role as a key inventor in the development of new adjuvants for vaccines. Her work continues to pave the way for advancements in immunology and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…